Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care

Ann Surg Oncol. 2022 Sep;29(9):5344-5346. doi: 10.1245/s10434-022-11915-4. Epub 2022 May 27.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Humans
  • Immunotherapy
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / therapy
  • Neoadjuvant Therapy
  • Neoplasm Staging